organic compounds
2-Ethylpiperidinium chloride
aSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, bVirginia Commonwealth University, Chemistry School, USA, cSchool of Chemical Sciences, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, and dX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia
*Correspondence e-mail: hkfun@usm.my
In the title molecular salt, C7H16N+·Cl−, the piperidinium ring adopts a chair conformation. In the crystal, the two components are connected by N—H⋯Cl and C—H⋯Cl hydrogen bonds, forming a supramolecular double-chain structure along the c axis.
Related literature
For biological applications of piperidine, see: Waelbroeck et al. (1992); El Hadri et al. (1995). For puckering parameters, see: Cremer & Pople (1975). For the stability of the temperature controller used in the data collection, see: Cosier & Glazer (1986).
Experimental
Crystal data
|
Refinement
|
Data collection: APEX2 (Bruker, 2009); cell SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009).
Supporting information
https://doi.org/10.1107/S1600536811036804/is2773sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536811036804/is2773Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S1600536811036804/is2773Isup3.cml
In a round bottom flask, 25ml of tetrahydronfuran (THF) was mixed with 2-ethylpiperidine (0.01 mol, 0.8 g) with stirring. Drops of benzylchloride (0.01 mol, 1.0 g) dissolved in THF was then added. The reaction mixture was refluxed for 30 min. The precipitate formed was washed with THF. The precipitate was then dissolved in methanol at room temperature. After few days, colourless needle-shaped crystals were formed by slow evaporation.
Atoms H1N1 and H2N1 were located from a difference Fourier maps and refined freely [N—H = 0.886 (13)–0.896 (14) Å]. The remaining H atoms were positioned geometrically (C—H = 0.98–1.00 Å) and were refined using a riding model, with Uiso(H) = 1.2 or 1.5 Ueq(C). A rotating group model was applied to the methyl groups.
Piperidine derivatives are the valued
in the field of medicinal chemistry. The piperidine nucleus is present in a wide range of biologically active compounds. For example, the binding properties of 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) and its analogs have been evaluated at muscarinic receptors in human neuroblastoma NB-OK1 cells (M1 receptor subtype), rat heart (M2 subtype), rat pancreas (M3 subtype) and the putative M4 receptor subtype in striatum (Waelbroeck et al., 1992). NMDA receptor antagonist properties of piperidine-2-carboxylic acid derivatives have also been reported (El Hadri et al., 1995). Herein, we have present the of the title compound (I).The θ = 180.00 (9)° and φ = 282 (7)° (Cremer & Pople, 1975). In the (Fig. 2), the cations and anions are connected by intermolecular N1—H1NA···Cl1, N1—H2NA···Cl1 and C1—H1A···Cl1 hydrogen bonds (Table 1), forming one-dimensional supramolecular chains along the c-axis.
of (I), (Fig. 1), consists of a 2-ethylpiperidinium cation and a chloride anion. The piperidine (N1/C1–C5) ring adopts a chair conformation with puckering parameters Q = 0.5708 (9) Å,For biological applications of piperidine, see: Waelbroeck et al. (1992); El Hadri et al. (1995). For puckering parameters, see: Cremer & Pople (1975). For the stability of the temperature controller used in the data collection, see: Cosier & Glazer (1986).
Data collection: APEX2 (Bruker, 2009); cell
SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).C7H16N+·Cl− | F(000) = 656 |
Mr = 149.66 | Dx = 1.157 Mg m−3 |
Orthorhombic, Pbcn | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2n 2ab | Cell parameters from 9898 reflections |
a = 24.2052 (6) Å | θ = 2.3–36.9° |
b = 9.7594 (3) Å | µ = 0.37 mm−1 |
c = 7.2764 (2) Å | T = 100 K |
V = 1718.89 (8) Å3 | Block, colourless |
Z = 8 | 0.72 × 0.27 × 0.15 mm |
Bruker SMART APEXII CCD area-detector diffractometer | 4453 independent reflections |
Radiation source: fine-focus sealed tube | 3438 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.045 |
φ and ω scans | θmax = 37.3°, θmin = 1.7° |
Absorption correction: multi-scan (SADABS; Bruker, 2009) | h = −40→40 |
Tmin = 0.778, Tmax = 0.948 | k = −16→16 |
50389 measured reflections | l = −12→12 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.040 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.088 | H atoms treated by a mixture of independent and constrained refinement |
S = 1.07 | w = 1/[σ2(Fo2) + (0.0343P)2 + 0.4206P] where P = (Fo2 + 2Fc2)/3 |
4453 reflections | (Δ/σ)max = 0.001 |
91 parameters | Δρmax = 0.34 e Å−3 |
0 restraints | Δρmin = −0.27 e Å−3 |
C7H16N+·Cl− | V = 1718.89 (8) Å3 |
Mr = 149.66 | Z = 8 |
Orthorhombic, Pbcn | Mo Kα radiation |
a = 24.2052 (6) Å | µ = 0.37 mm−1 |
b = 9.7594 (3) Å | T = 100 K |
c = 7.2764 (2) Å | 0.72 × 0.27 × 0.15 mm |
Bruker SMART APEXII CCD area-detector diffractometer | 4453 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 2009) | 3438 reflections with I > 2σ(I) |
Tmin = 0.778, Tmax = 0.948 | Rint = 0.045 |
50389 measured reflections |
R[F2 > 2σ(F2)] = 0.040 | 0 restraints |
wR(F2) = 0.088 | H atoms treated by a mixture of independent and constrained refinement |
S = 1.07 | Δρmax = 0.34 e Å−3 |
4453 reflections | Δρmin = −0.27 e Å−3 |
91 parameters |
Experimental. The crystal was placed in the cold stream of an Oxford Cryosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K. |
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
N1 | 0.39971 (3) | 0.13082 (7) | 0.95142 (9) | 0.01471 (11) | |
C1 | 0.45090 (3) | 0.18923 (8) | 1.03505 (12) | 0.01927 (15) | |
H1A | 0.4838 | 0.1482 | 0.9761 | 0.023* | |
H1B | 0.4520 | 0.1670 | 1.1678 | 0.023* | |
C2 | 0.45182 (4) | 0.34373 (9) | 1.00941 (12) | 0.02298 (17) | |
H2A | 0.4543 | 0.3655 | 0.8768 | 0.028* | |
H2B | 0.4848 | 0.3823 | 1.0710 | 0.028* | |
C3 | 0.39979 (4) | 0.40873 (9) | 1.08969 (12) | 0.02384 (17) | |
H3A | 0.3999 | 0.5084 | 1.0647 | 0.029* | |
H3B | 0.3993 | 0.3955 | 1.2246 | 0.029* | |
C4 | 0.34807 (4) | 0.34393 (8) | 1.00500 (12) | 0.01959 (15) | |
H4A | 0.3148 | 0.3837 | 1.0638 | 0.024* | |
H4B | 0.3467 | 0.3664 | 0.8724 | 0.024* | |
C5 | 0.34710 (3) | 0.18860 (8) | 1.02842 (10) | 0.01526 (13) | |
H5A | 0.3452 | 0.1667 | 1.1625 | 0.018* | |
C6 | 0.29921 (4) | 0.11725 (8) | 0.93081 (12) | 0.01881 (14) | |
H6A | 0.3011 | 0.1382 | 0.7978 | 0.023* | |
H6B | 0.3033 | 0.0169 | 0.9455 | 0.023* | |
C7 | 0.24270 (4) | 0.16025 (11) | 1.00354 (15) | 0.02814 (19) | |
H7A | 0.2138 | 0.1106 | 0.9369 | 0.042* | |
H7B | 0.2378 | 0.2590 | 0.9855 | 0.042* | |
H7C | 0.2403 | 0.1388 | 1.1349 | 0.042* | |
H1NA | 0.4002 (5) | 0.0410 (14) | 0.9689 (17) | 0.021 (3)* | |
H2NA | 0.4007 (4) | 0.1476 (13) | 0.830 (2) | 0.024 (3)* | |
Cl1 | 0.401145 (8) | 0.182057 (18) | 0.52892 (2) | 0.01611 (5) |
U11 | U22 | U33 | U12 | U13 | U23 | |
N1 | 0.0164 (3) | 0.0142 (3) | 0.0135 (3) | 0.0003 (2) | 0.0004 (2) | 0.0007 (2) |
C1 | 0.0173 (3) | 0.0207 (3) | 0.0198 (3) | −0.0028 (3) | −0.0031 (3) | 0.0026 (3) |
C2 | 0.0263 (4) | 0.0213 (4) | 0.0213 (4) | −0.0086 (3) | −0.0037 (3) | 0.0031 (3) |
C3 | 0.0368 (5) | 0.0158 (3) | 0.0189 (3) | −0.0042 (3) | −0.0016 (3) | −0.0012 (3) |
C4 | 0.0254 (4) | 0.0137 (3) | 0.0197 (3) | 0.0020 (3) | 0.0015 (3) | 0.0000 (3) |
C5 | 0.0176 (3) | 0.0142 (3) | 0.0140 (3) | 0.0010 (2) | 0.0026 (3) | 0.0008 (2) |
C6 | 0.0166 (3) | 0.0188 (3) | 0.0210 (3) | −0.0001 (3) | 0.0004 (3) | 0.0002 (3) |
C7 | 0.0186 (4) | 0.0286 (4) | 0.0372 (5) | 0.0007 (3) | 0.0062 (4) | 0.0015 (4) |
Cl1 | 0.02022 (9) | 0.01473 (8) | 0.01339 (7) | −0.00044 (6) | 0.00104 (6) | 0.00007 (5) |
N1—C1 | 1.4935 (11) | C3—H3B | 0.9900 |
N1—C5 | 1.5012 (10) | C4—C5 | 1.5256 (11) |
N1—H1NA | 0.886 (13) | C4—H4A | 0.9900 |
N1—H2NA | 0.896 (14) | C4—H4B | 0.9900 |
C1—C2 | 1.5195 (12) | C5—C6 | 1.5275 (11) |
C1—H1A | 0.9900 | C5—H5A | 1.0000 |
C1—H1B | 0.9900 | C6—C7 | 1.5256 (13) |
C2—C3 | 1.5264 (14) | C6—H6A | 0.9900 |
C2—H2A | 0.9900 | C6—H6B | 0.9900 |
C2—H2B | 0.9900 | C7—H7A | 0.9800 |
C3—C4 | 1.5318 (13) | C7—H7B | 0.9800 |
C3—H3A | 0.9900 | C7—H7C | 0.9800 |
C1—N1—C5 | 114.10 (6) | C5—C4—C3 | 112.20 (7) |
C1—N1—H1NA | 108.0 (7) | C5—C4—H4A | 109.2 |
C5—N1—H1NA | 109.2 (7) | C3—C4—H4A | 109.2 |
C1—N1—H2NA | 108.0 (7) | C5—C4—H4B | 109.2 |
C5—N1—H2NA | 108.7 (7) | C3—C4—H4B | 109.2 |
H1NA—N1—H2NA | 108.7 (11) | H4A—C4—H4B | 107.9 |
N1—C1—C2 | 109.93 (7) | N1—C5—C4 | 108.57 (7) |
N1—C1—H1A | 109.7 | N1—C5—C6 | 107.40 (6) |
C2—C1—H1A | 109.7 | C4—C5—C6 | 114.38 (7) |
N1—C1—H1B | 109.7 | N1—C5—H5A | 108.8 |
C2—C1—H1B | 109.7 | C4—C5—H5A | 108.8 |
H1A—C1—H1B | 108.2 | C6—C5—H5A | 108.8 |
C1—C2—C3 | 110.69 (7) | C7—C6—C5 | 113.19 (7) |
C1—C2—H2A | 109.5 | C7—C6—H6A | 108.9 |
C3—C2—H2A | 109.5 | C5—C6—H6A | 108.9 |
C1—C2—H2B | 109.5 | C7—C6—H6B | 108.9 |
C3—C2—H2B | 109.5 | C5—C6—H6B | 108.9 |
H2A—C2—H2B | 108.1 | H6A—C6—H6B | 107.8 |
C2—C3—C4 | 110.41 (7) | C6—C7—H7A | 109.5 |
C2—C3—H3A | 109.6 | C6—C7—H7B | 109.5 |
C4—C3—H3A | 109.6 | H7A—C7—H7B | 109.5 |
C2—C3—H3B | 109.6 | C6—C7—H7C | 109.5 |
C4—C3—H3B | 109.6 | H7A—C7—H7C | 109.5 |
H3A—C3—H3B | 108.1 | H7B—C7—H7C | 109.5 |
C5—N1—C1—C2 | −58.09 (9) | C1—N1—C5—C6 | −179.25 (6) |
N1—C1—C2—C3 | 56.11 (9) | C3—C4—C5—N1 | −54.61 (9) |
C1—C2—C3—C4 | −55.59 (9) | C3—C4—C5—C6 | −174.51 (7) |
C2—C3—C4—C5 | 55.68 (9) | N1—C5—C6—C7 | 176.69 (7) |
C1—N1—C5—C4 | 56.59 (8) | C4—C5—C6—C7 | −62.75 (10) |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1NA···Cl1i | 0.886 (14) | 2.220 (14) | 3.1054 (7) | 176.9 (11) |
N1—H2NA···Cl1 | 0.899 (15) | 2.217 (15) | 3.1149 (7) | 177.8 (12) |
C1—H1A···Cl1ii | 0.99 | 2.80 | 3.6121 (8) | 139 |
Symmetry codes: (i) x, −y, z+1/2; (ii) −x+1, y, −z+3/2. |
Experimental details
Crystal data | |
Chemical formula | C7H16N+·Cl− |
Mr | 149.66 |
Crystal system, space group | Orthorhombic, Pbcn |
Temperature (K) | 100 |
a, b, c (Å) | 24.2052 (6), 9.7594 (3), 7.2764 (2) |
V (Å3) | 1718.89 (8) |
Z | 8 |
Radiation type | Mo Kα |
µ (mm−1) | 0.37 |
Crystal size (mm) | 0.72 × 0.27 × 0.15 |
Data collection | |
Diffractometer | Bruker SMART APEXII CCD area-detector |
Absorption correction | Multi-scan (SADABS; Bruker, 2009) |
Tmin, Tmax | 0.778, 0.948 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 50389, 4453, 3438 |
Rint | 0.045 |
(sin θ/λ)max (Å−1) | 0.852 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.040, 0.088, 1.07 |
No. of reflections | 4453 |
No. of parameters | 91 |
H-atom treatment | H atoms treated by a mixture of independent and constrained refinement |
Δρmax, Δρmin (e Å−3) | 0.34, −0.27 |
Computer programs: APEX2 (Bruker, 2009), SAINT (Bruker, 2009), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1NA···Cl1i | 0.886 (14) | 2.220 (14) | 3.1054 (7) | 176.9 (11) |
N1—H2NA···Cl1 | 0.899 (15) | 2.217 (15) | 3.1149 (7) | 177.8 (12) |
C1—H1A···Cl1ii | 0.99 | 2.80 | 3.6121 (8) | 139 |
Symmetry codes: (i) x, −y, z+1/2; (ii) −x+1, y, −z+3/2. |
Footnotes
‡Thomson Reuters ResearcherID: A-3561-2009.
Acknowledgements
AS gratefully acknowledges funding from Universiti Sains Malaysia (USM) under the University Research Grant (No. 1001/PKIMIA/811055). HKF and MH thank the Malaysian Government and Universiti Sains Malaysia for the Research University Grant No. 1001/PFIZIK/811160. MH also thanks Universiti Sains Malaysia for a post-doctoral research fellowship.
References
Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Cosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105–107. CrossRef CAS Web of Science IUCr Journals Google Scholar
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354–1358. CrossRef CAS Web of Science Google Scholar
El Hadri, A., Maldivi, P., Leclerc, G. & Rocher, J.-P. (1995). Bioorg. Med. Chem. 3, 1183–1201. CrossRef CAS PubMed Web of Science Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Waelbroeck, M., Camus, J., Tastenoy, M. & Christophe, J. (1992). Br. J. Pharmacol. 105, 97–102. CrossRef PubMed CAS Web of Science Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Piperidine derivatives are the valued heterocyclic compounds in the field of medicinal chemistry. The piperidine nucleus is present in a wide range of biologically active compounds. For example, the binding properties of 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) and its analogs have been evaluated at muscarinic receptors in human neuroblastoma NB-OK1 cells (M1 receptor subtype), rat heart (M2 subtype), rat pancreas (M3 subtype) and the putative M4 receptor subtype in striatum (Waelbroeck et al., 1992). NMDA receptor antagonist properties of piperidine-2-carboxylic acid derivatives have also been reported (El Hadri et al., 1995). Herein, we have present the crystal structure of the title compound (I).
The asymmetric unit of (I), (Fig. 1), consists of a 2-ethylpiperidinium cation and a chloride anion. The piperidine (N1/C1–C5) ring adopts a chair conformation with puckering parameters Q = 0.5708 (9) Å, θ = 180.00 (9)° and φ = 282 (7)° (Cremer & Pople, 1975). In the crystal structure (Fig. 2), the cations and anions are connected by intermolecular N1—H1NA···Cl1, N1—H2NA···Cl1 and C1—H1A···Cl1 hydrogen bonds (Table 1), forming one-dimensional supramolecular chains along the c-axis.